EPOCH-O Regimen
Go to external page
http://purl.obolibrary.org/obo/NCIT_C136414
An immune-chemotherapy regimen consisting of etoposide, prednisone, vincristine (Oncovin), cyclophosphamide, doxorubicin (hydroxydaunorubicin) and ofatumumab, which may be used for the treatment of various aggressive non-Hodgkin lymphomas. [ ]
Term info
Label
EPOCH-O Regimen
Synonyms
- DA EPOCH-O
- Dose-Adjusted Etoposide-Prednisone- Vincristine-Cyclophosphamide-Ofatumumab
- Dose-adjusted EPOCH-Ofatumumab
- Dose-adjusted Etoposide/Vincristine/Doxorubicin/Cyclophosphamide/Prednisone Plus Ofatumumab Regimen
- EPOCH Plus Arzerra
- EPOCH Plus Ofatumumab
- EPOCH-O
- EPOCH-O Regimen
- Etoposide-Prednisone-Oncovin-Cyclophosphamide-Hydroxydaunorubicin-Ofatumumab Regimen
- O-EPOCH
- O-EPOCH Regimen
Subsets
NCIT_C160952, NCIT_C160950
NCI META CUI
CL523718
PDQ Closed Trial Search ID
789512
PDQ Open Trial Search ID
789512
Preferred Name
EPOCH-O Regimen
Semantic Type
Therapeutic or Preventive Procedure
code
C136414
Term relations
Subclass of:
- Regimen Used to Treat Non-Hodgkin Lymphoma
- Chemotherapy_Regimen_Has_Component some Vincristine
- Chemotherapy_Regimen_Has_Component some Ofatumumab
- Chemotherapy_Regimen_Has_Component some Doxorubicin Hydrochloride
- Chemotherapy_Regimen_Has_Component some Etoposide
- Chemotherapy_Regimen_Has_Component some Prednisone
- Chemotherapy_Regimen_Has_Component some Cyclophosphamide